Sri Lanka vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB

Sri Lanka
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Sri Lanka rank
1st
Western Pacific (WHO region) rank
3rd

Previously treated cases tested for RR-/MDR-TB over time

  • Sri Lanka
  • Western Pacific (WHO region)
020406080100200520142024

How they compare

Sri Lanka currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.

That makes Sri Lanka's figure about 1.2 times Western Pacific (WHO region)'s.

The two have swapped places 6 times across 19 shared years of data; in 2005 it was Sri Lanka ahead.

Sri Lanka ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.

Across the 3 decades both report, Sri Lanka averaged higher in 2 and Western Pacific (WHO region) in 1.

Head to head by decade

Decade Sri Lanka Western Pacific (WHO region) Difference Ahead
2000s 86.0% 1.0% 85.0% Sri Lanka
2010s 85.6% 54.9% 30.7% Sri Lanka
2020s 81.5% 88.5% 7.0% Western Pacific (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Sri Lanka or Western Pacific (WHO region)?
Sri Lanka, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Sri Lanka and Western Pacific (WHO region)?
14.0%, with Sri Lanka ahead.
How many years of comparable data are there for Sri Lanka and Western Pacific (WHO region)?
19 years are reported by both, from 2005 to 2024.
How do Sri Lanka and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
Sri Lanka ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Sri Lanka vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 12 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/sri-lanka/western-pacific-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/sri-lanka/western-pacific-who-region/">Sri Lanka vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed